Get the clinical insights most relevant to you and your patients

You see a broad list of patient types and treat a wide range of conditions, requiring information on a case-by-case, patient-by-patient basis. That’s why Quest Diagnostics offers Primary Insights, a site for healthcare professionals, their practices, and their staff. Find the insights you need, when you need them, for improved patient care. Quest provides clinical insights and testing information that can help you support organizational guidelines for all patient, visit, and condition types.
Transplantation: Laboratory Testing for Screening and Monitoring Infectious Diseases 
This article will discuss the importance of laboratory testing for patients who donate and receive transplants, with a focus on screening and monitoring for infectious diseases.
Colorectal Cancer Screening During the Pandemic 
This article will discuss CRC, the effect the COVID-19 pandemic on screening and diagnosis, and how the laboratory can help provide options for safe CRC screening during the pandemic. 

Chronic Kidney Disease: Laboratory Support of Diagnosis and Management
This article will discuss CKD, its risk factors and comorbidities, and how the laboratory can assist in diagnosis and management.

Neurological Diseases and COVID-19
This article will discuss current knowledge of the association of COVID-19 with neurological disease and how the laboratory can help in the diagnosis and management of patients with COVID-19 and neurological complications.

Cardiovascular Disease, Influenza, and COVID-19
This article will discuss associations of cardiovascular disease risk and outcomes with seasonal influenza, as well as emerging information on associations with COVID-19. Laboratory testing is important for recognizing potential cardiovascular effects of these illnesses.

Celiac Disease: Laboratory Support for Diagnosis
This article will discuss celiac disease and the role of laboratory testing in diagnosis.

Hepatitis C—New Guidelines Expand Screening Recommendations
This article will discuss HCV infection and new screening guidelines. The guidelines reflect the changing demographics of high-risk populations, which have been influenced by the opioid epidemic in recent years.

Hereditary Breast Cancer
This article will discuss hereditary breast cancer, and how genetic testing can be used to assess risk. 

Autoimmune Rheumatic Diseases: Diagnosis and Management
This article will review ARDs and the importance of early and accurate diagnosis. It will discuss the importance of laboratory testing for autoantibodies and how antibody panels can help to rule in or rule out common autoimmune diseases.

Colorectal Cancer Screening: Guideline Recommends Starting at a Younger Age
This article will review CRC and discuss the 2018 ACS screening recommendations and options for persons with an average risk of developing CRC. 

Cardiovascular Disease, Diabetes, and COVID-19
This article will discuss COVID-19 and the comorbidities of cardiovascular disease (CVD) and diabetes. People with these conditions are more likely to contract a severe COVID-19 infection and are among those identified as being at higher risk for poorer outcomes.

Laboratory Testing for COVID-19
This article discusses current laboratory testing for the diagnosis of COVID-19 and assessment of past infection. 

Melanoma: Prevention and Early Detection
This article will discuss prevention and early detection of melanoma. It will also explain a simple method that patients can use to screen themselves, and how the lab can help patients with melanoma.

Heart Failure Prevention, Diagnosis, and Management
This article will discuss the role of natriuretic peptides and other biomarkers in the prevention, diagnosis, and management of heart failure, and focus on the 2017 update of the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) recommendations for the use of biomarkers in heart failure.5
Subscribe to Primary Insights

Get the clinical insights most relevant to you and your patients, from the lab committed to knowing.